FTD SARS-CoV-2 Assay

FTD SARS-CoV-2 Assay1For the specific detection of the novel coronavirus causing COVID-19

In late 2019, China notified the World Health Organization (WHO) of a novel strain of coronavirus. This virus, now named SARS-CoV-2, targets the epithelial cells of the respiratory tract and causes infection that can lead to Coronavirus disease 2019 (COVID-19). Siemens Healthineers new molecular assay uses real-time PCR to detect RNA from this virus.

Contact a Representative

Features & Benefits

  • Kit comprised of a single-well dual target assay for the specific detection of SARS-CoV-2 (COVID-19)
  • Designed for high sensitivity, specificity, and inclusivity
  • Covers highly conserved regions within ORF1ab and N gene
  • Uses the same assay setup protocol and thermal-cycling profile as all FTD respiratory disease kits2

Learn more about the FTD SARS-CoV-2 Assay and Emerging Variants


Download our infographic to learn more about the dual-target design of the FTD SARS-CoV-2 assays.

Complete the form to download the infographic and receive more information from a Siemens Healthineers expert.